Feedback / Questions
NTX1088 - Nectin Therap
https://www.prnewswire.com/news-releases/gibf-invests-10-million-in-nectin-therapeutics-to-advance-novel-pipeline-of-first-in-class-immunotherapies-and-antibody-drug-conjugates-302136519.html
May 6, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next